MAPK signaling leads to TLE1 phosphorylation and inhibits TLE1 suppressive activity by translocating it from the nucleus to the cytoplasm in tumor cell lines (Zahavi et al., 2017). The gene discussed is TLE1; the disease is neoplasm.